Artificial and bioartificial support systems for liver failure: a Cochrane Hepato-Biliary Group Protocol
: Aims/Background: Liver support systems may bridge patients to liver transplantation or recovery from liver failure. This review is to evaluate the beneficial and harmful effects of artificial and bioartificial support systems for acute and acute‐on‐chronic liver failure. Data Sources: Randomized t...
Gespeichert in:
| Veröffentlicht in: | Liver (Copenhagen) 2002-10, Vol.22 (5), p.433-438 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 438 |
|---|---|
| container_issue | 5 |
| container_start_page | 433 |
| container_title | Liver (Copenhagen) |
| container_volume | 22 |
| creator | Liu, Jianping Kjaergard, Lise Lotte Als-Nielsen, Bodil Gluud, Christian |
| description | : Aims/Background: Liver support systems may bridge patients to liver transplantation or recovery from liver failure. This review is to evaluate the beneficial and harmful effects of artificial and bioartificial support systems for acute and acute‐on‐chronic liver failure.
Data Sources: Randomized trials on any support system versus standard medical therapy will be included irrespective of publication status or language. Non‐randomized studies are included in explorative analyses. Trials will be identified through bibliographies, correspondence with original investigators, and electronic searches (Cochrane Hepato‐Biliary Group Controlled Trials Register, Cochrane Controlled Trials Register, MEDLINE, EMBASE, and The Chinese Biomedical Database).
Methods of the review: The extracted data will include characteristics of trials, patients, interventions, and all outcome measures. Methodological quality will be assessed by the randomization, follow up, and blinding. The RevMan and STATA will be used for statistical analyses. Sources of heterogeneity and methodological quality in the assessment of the primary outcome will be explored by sensitivity analyses and meta‐regression. |
| doi_str_mv | 10.1034/j.1600-0676.2002.01554.x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72519975</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72519975</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4834-dfe040c1cbade78e6004f8fe2a570d1f406472ecfc05a5033fc4110af1ca6f793</originalsourceid><addsrcrecordid>eNqNkUFv2yAUx9G0qc26foWJy3az-zBg7Ek7tNGWVoq2Hdb0iAgGlYwUD-wt-fbDTdRcdwLB78977wdCmEBJgLKrTUlqgAJqUZcVQFUC4ZyVu1do9nLxGs2AQF20nNFz9DalDQCpmeBn6JxUtAUm2hl6vI6Ds0475bF66vDaBXU6SWPfhzjgtE-D2SZsQ8Te_TERW-X8GM0nrPA86Meongy-Nb0aQnHjvFNxjxcxjD3-EcMQdPDv0BurfDKXx_UC3X_98nN-Wyy_L-7m18tCs4ayorMGGGii16ozojF5GmYbayrFBXTEMsgjVEZbDVxxoNRqRggoS7SqrWjpBfp4eLeP4fdo0iC3Lmnjfe4wjEmKipO2FTyDzQHUMaQUjZV9dNvcuCQgJ8tyIyeZcpIpJ8vy2bLc5ej7Y41xvTXdKXjUmoEPR0AlrbzNerRLJ46RtmpYlbnPB-6v82b_3w3I5d1q2uV8cci7_D-7l7yKv2QtqODy4dtCzmG1Wi2rVgr6DxMjqKo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72519975</pqid></control><display><type>article</type><title>Artificial and bioartificial support systems for liver failure: a Cochrane Hepato-Biliary Group Protocol</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Liu, Jianping ; Kjaergard, Lise Lotte ; Als-Nielsen, Bodil ; Gluud, Christian</creator><creatorcontrib>Liu, Jianping ; Kjaergard, Lise Lotte ; Als-Nielsen, Bodil ; Gluud, Christian</creatorcontrib><description>: Aims/Background: Liver support systems may bridge patients to liver transplantation or recovery from liver failure. This review is to evaluate the beneficial and harmful effects of artificial and bioartificial support systems for acute and acute‐on‐chronic liver failure.
Data Sources: Randomized trials on any support system versus standard medical therapy will be included irrespective of publication status or language. Non‐randomized studies are included in explorative analyses. Trials will be identified through bibliographies, correspondence with original investigators, and electronic searches (Cochrane Hepato‐Biliary Group Controlled Trials Register, Cochrane Controlled Trials Register, MEDLINE, EMBASE, and The Chinese Biomedical Database).
Methods of the review: The extracted data will include characteristics of trials, patients, interventions, and all outcome measures. Methodological quality will be assessed by the randomization, follow up, and blinding. The RevMan and STATA will be used for statistical analyses. Sources of heterogeneity and methodological quality in the assessment of the primary outcome will be explored by sensitivity analyses and meta‐regression.</description><identifier>ISSN: 0106-9543</identifier><identifier>EISSN: 1600-0676</identifier><identifier>DOI: 10.1034/j.1600-0676.2002.01554.x</identifier><identifier>PMID: 12390479</identifier><identifier>CODEN: LIVEDR</identifier><language>eng</language><publisher>Oxford, UK: Munksgaard International Publishers</publisher><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; artificial liver ; Biological and medical sciences ; Chronic Disease ; Clinical Protocols ; Cochrane ; Controlled Clinical Trials as Topic ; Emergency and intensive care: metabolism and nutrition disorders. Enteral and parenteral nutrition ; extracorporeal liver support ; Gastroenterology - methods ; Humans ; hybrid devices ; Intensive care medicine ; life support care ; liver failure ; Liver Failure, Acute - therapy ; liver transplantation ; Liver, Artificial ; Medical sciences ; Sorption Detoxification - instrumentation ; Sorption Detoxification - methods ; systematic review ; Tropical medicine</subject><ispartof>Liver (Copenhagen), 2002-10, Vol.22 (5), p.433-438</ispartof><rights>2002 INIST-CNRS</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4834-dfe040c1cbade78e6004f8fe2a570d1f406472ecfc05a5033fc4110af1ca6f793</citedby><cites>FETCH-LOGICAL-c4834-dfe040c1cbade78e6004f8fe2a570d1f406472ecfc05a5033fc4110af1ca6f793</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1034%2Fj.1600-0676.2002.01554.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1034%2Fj.1600-0676.2002.01554.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14192842$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12390479$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liu, Jianping</creatorcontrib><creatorcontrib>Kjaergard, Lise Lotte</creatorcontrib><creatorcontrib>Als-Nielsen, Bodil</creatorcontrib><creatorcontrib>Gluud, Christian</creatorcontrib><title>Artificial and bioartificial support systems for liver failure: a Cochrane Hepato-Biliary Group Protocol</title><title>Liver (Copenhagen)</title><addtitle>Liver</addtitle><description>: Aims/Background: Liver support systems may bridge patients to liver transplantation or recovery from liver failure. This review is to evaluate the beneficial and harmful effects of artificial and bioartificial support systems for acute and acute‐on‐chronic liver failure.
Data Sources: Randomized trials on any support system versus standard medical therapy will be included irrespective of publication status or language. Non‐randomized studies are included in explorative analyses. Trials will be identified through bibliographies, correspondence with original investigators, and electronic searches (Cochrane Hepato‐Biliary Group Controlled Trials Register, Cochrane Controlled Trials Register, MEDLINE, EMBASE, and The Chinese Biomedical Database).
Methods of the review: The extracted data will include characteristics of trials, patients, interventions, and all outcome measures. Methodological quality will be assessed by the randomization, follow up, and blinding. The RevMan and STATA will be used for statistical analyses. Sources of heterogeneity and methodological quality in the assessment of the primary outcome will be explored by sensitivity analyses and meta‐regression.</description><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>artificial liver</subject><subject>Biological and medical sciences</subject><subject>Chronic Disease</subject><subject>Clinical Protocols</subject><subject>Cochrane</subject><subject>Controlled Clinical Trials as Topic</subject><subject>Emergency and intensive care: metabolism and nutrition disorders. Enteral and parenteral nutrition</subject><subject>extracorporeal liver support</subject><subject>Gastroenterology - methods</subject><subject>Humans</subject><subject>hybrid devices</subject><subject>Intensive care medicine</subject><subject>life support care</subject><subject>liver failure</subject><subject>Liver Failure, Acute - therapy</subject><subject>liver transplantation</subject><subject>Liver, Artificial</subject><subject>Medical sciences</subject><subject>Sorption Detoxification - instrumentation</subject><subject>Sorption Detoxification - methods</subject><subject>systematic review</subject><subject>Tropical medicine</subject><issn>0106-9543</issn><issn>1600-0676</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkUFv2yAUx9G0qc26foWJy3az-zBg7Ek7tNGWVoq2Hdb0iAgGlYwUD-wt-fbDTdRcdwLB78977wdCmEBJgLKrTUlqgAJqUZcVQFUC4ZyVu1do9nLxGs2AQF20nNFz9DalDQCpmeBn6JxUtAUm2hl6vI6Ds0475bF66vDaBXU6SWPfhzjgtE-D2SZsQ8Te_TERW-X8GM0nrPA86Meongy-Nb0aQnHjvFNxjxcxjD3-EcMQdPDv0BurfDKXx_UC3X_98nN-Wyy_L-7m18tCs4ayorMGGGii16ozojF5GmYbayrFBXTEMsgjVEZbDVxxoNRqRggoS7SqrWjpBfp4eLeP4fdo0iC3Lmnjfe4wjEmKipO2FTyDzQHUMaQUjZV9dNvcuCQgJ8tyIyeZcpIpJ8vy2bLc5ej7Y41xvTXdKXjUmoEPR0AlrbzNerRLJ46RtmpYlbnPB-6v82b_3w3I5d1q2uV8cci7_D-7l7yKv2QtqODy4dtCzmG1Wi2rVgr6DxMjqKo</recordid><startdate>200210</startdate><enddate>200210</enddate><creator>Liu, Jianping</creator><creator>Kjaergard, Lise Lotte</creator><creator>Als-Nielsen, Bodil</creator><creator>Gluud, Christian</creator><general>Munksgaard International Publishers</general><general>Munksgaard</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200210</creationdate><title>Artificial and bioartificial support systems for liver failure: a Cochrane Hepato-Biliary Group Protocol</title><author>Liu, Jianping ; Kjaergard, Lise Lotte ; Als-Nielsen, Bodil ; Gluud, Christian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4834-dfe040c1cbade78e6004f8fe2a570d1f406472ecfc05a5033fc4110af1ca6f793</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>artificial liver</topic><topic>Biological and medical sciences</topic><topic>Chronic Disease</topic><topic>Clinical Protocols</topic><topic>Cochrane</topic><topic>Controlled Clinical Trials as Topic</topic><topic>Emergency and intensive care: metabolism and nutrition disorders. Enteral and parenteral nutrition</topic><topic>extracorporeal liver support</topic><topic>Gastroenterology - methods</topic><topic>Humans</topic><topic>hybrid devices</topic><topic>Intensive care medicine</topic><topic>life support care</topic><topic>liver failure</topic><topic>Liver Failure, Acute - therapy</topic><topic>liver transplantation</topic><topic>Liver, Artificial</topic><topic>Medical sciences</topic><topic>Sorption Detoxification - instrumentation</topic><topic>Sorption Detoxification - methods</topic><topic>systematic review</topic><topic>Tropical medicine</topic><toplevel>online_resources</toplevel><creatorcontrib>Liu, Jianping</creatorcontrib><creatorcontrib>Kjaergard, Lise Lotte</creatorcontrib><creatorcontrib>Als-Nielsen, Bodil</creatorcontrib><creatorcontrib>Gluud, Christian</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Liver (Copenhagen)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Jianping</au><au>Kjaergard, Lise Lotte</au><au>Als-Nielsen, Bodil</au><au>Gluud, Christian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Artificial and bioartificial support systems for liver failure: a Cochrane Hepato-Biliary Group Protocol</atitle><jtitle>Liver (Copenhagen)</jtitle><addtitle>Liver</addtitle><date>2002-10</date><risdate>2002</risdate><volume>22</volume><issue>5</issue><spage>433</spage><epage>438</epage><pages>433-438</pages><issn>0106-9543</issn><eissn>1600-0676</eissn><coden>LIVEDR</coden><abstract>: Aims/Background: Liver support systems may bridge patients to liver transplantation or recovery from liver failure. This review is to evaluate the beneficial and harmful effects of artificial and bioartificial support systems for acute and acute‐on‐chronic liver failure.
Data Sources: Randomized trials on any support system versus standard medical therapy will be included irrespective of publication status or language. Non‐randomized studies are included in explorative analyses. Trials will be identified through bibliographies, correspondence with original investigators, and electronic searches (Cochrane Hepato‐Biliary Group Controlled Trials Register, Cochrane Controlled Trials Register, MEDLINE, EMBASE, and The Chinese Biomedical Database).
Methods of the review: The extracted data will include characteristics of trials, patients, interventions, and all outcome measures. Methodological quality will be assessed by the randomization, follow up, and blinding. The RevMan and STATA will be used for statistical analyses. Sources of heterogeneity and methodological quality in the assessment of the primary outcome will be explored by sensitivity analyses and meta‐regression.</abstract><cop>Oxford, UK</cop><pub>Munksgaard International Publishers</pub><pmid>12390479</pmid><doi>10.1034/j.1600-0676.2002.01554.x</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0106-9543 |
| ispartof | Liver (Copenhagen), 2002-10, Vol.22 (5), p.433-438 |
| issn | 0106-9543 1600-0676 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_72519975 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy artificial liver Biological and medical sciences Chronic Disease Clinical Protocols Cochrane Controlled Clinical Trials as Topic Emergency and intensive care: metabolism and nutrition disorders. Enteral and parenteral nutrition extracorporeal liver support Gastroenterology - methods Humans hybrid devices Intensive care medicine life support care liver failure Liver Failure, Acute - therapy liver transplantation Liver, Artificial Medical sciences Sorption Detoxification - instrumentation Sorption Detoxification - methods systematic review Tropical medicine |
| title | Artificial and bioartificial support systems for liver failure: a Cochrane Hepato-Biliary Group Protocol |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T17%3A37%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Artificial%20and%20bioartificial%20support%20systems%20for%20liver%20failure:%20a%20Cochrane%20Hepato-Biliary%20Group%20Protocol&rft.jtitle=Liver%20(Copenhagen)&rft.au=Liu,%20Jianping&rft.date=2002-10&rft.volume=22&rft.issue=5&rft.spage=433&rft.epage=438&rft.pages=433-438&rft.issn=0106-9543&rft.eissn=1600-0676&rft.coden=LIVEDR&rft_id=info:doi/10.1034/j.1600-0676.2002.01554.x&rft_dat=%3Cproquest_cross%3E72519975%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72519975&rft_id=info:pmid/12390479&rfr_iscdi=true |